Alfred Guirguis, DO
Gynecologic Oncology · Oak Lawn, ILNPI 1063539211
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,323 of the $43,887 with a category attached, or 73.6%. 34 manufacturers reported payments, led by Baxter Healthcare at 39.6% of the total. Reporting peaked in 2020 at $22,593 and has fallen 95.1% since, to $1,100 in 2025. Among gynecologic oncology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $189.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$17K
- AstraZeneca$15K
- Seagen Inc.$7K
- Intuitive Surgical$918
- Merck$876
- Eisai Inc.$408
- plus $2K from 28 others
Across 12 payments — averaging $3503.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$38K
- Karyopharm Therapeutics Inc.$3K
- Novartis$1K
What the payments were for
- Consulting fees$3,4918%
- Speaking & faculty fees$32,32374%
- Travel & lodging$2,4035%
- Food & beverage$5,49413%
- Education$1760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 18 | $17,377 |
| AstraZeneca | 38 | $15,194 |
| Seagen Inc. | 16 | $6,899 |
| Intuitive Surgical | 7 | $918 |
| Merck | 40 | $876 |
| Eisai Inc. | 21 | $408 |
| GSK | 12 | $323 |
| Amgen | 10 | $221 |
| Clovis Oncology, Inc. | 12 | $209 |
| Amneal Pharmaceuticals LLC | 7 | $185 |
| Pfizer | 6 | $120 |
| AbbVie | 5 | $114 |
| On Target Laboratories, Inc | 1 | $97 |
| Astellas Pharma US Inc | 4 | $91 |
| Novartis | 3 | $87 |
| Genentech USA, Inc. | 4 | $85 |
| Tempus AI, Inc | 3 | $81 |
| Foundation Medicine, Inc. | 4 | $74 |
| Myriad Genetic Laboratories, Inc. | 3 | $67 |
| Abbott | 1 | $62 |
| Aspira Women's Health Inc | 3 | $51 |
| Medtronic | 1 | $47 |
| Menarini Silicon Biosystems, Inc. | 1 | $38 |
| Tactile Systems Technology Inc | 1 | $32 |
| Coherus Oncology, Inc. | 1 | $31 |
| Johnson & Johnson | 1 | $31 |
| Caris MPI, Inc. | 1 | $27 |
| Celltrion USA Inc. | 1 | $27 |
| Incyte Corporation | 1 | $23 |
| Tesaro, Inc. | 1 | $23 |
| Spectrum Pharmaceuticals Inc. | 1 | $22 |
| Immunogen, Inc. | 1 | $19 |
| Dysis Medical, Inc. | 1 | $13 |
| Duchesnay USA Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOSEAL$16,713
- TISSEEL$16,133
- LYNPARZA$14,275
- TIVDAK$6,514
- Da Vinci Surgical System$479
- COSEAL$302
- DA VINCI SP$208
How this compares
$43,887 in reported general payments places this provider in the 90th percentile of 64 gynecologic oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 23 | $2,235 |
| Dexamethasone | 19 | $389 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $357 |
| Ibuprofen | 55 | $213 |
| Gabapentin | 15 | $148 |
| Tramadol Hcl | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Oak Lawn
- Michael LoweOak Lawn$9K
- Carrie McIlwainOak Lawn$1K
- Nikki NeubauerOak Lawn$672
- Amina AhmedChicago$1.1M
- Dario RoqueChicago$587K
- Jenna MarcusChicago$230K
- Raanan AlterWarrenville$128K
- Emily HinchcliffChicago$62K
- Summer DewdneyChicago$59K
- Kathryn MillsChicago$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.